432 participants
A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-06-13
- Start Date:
- 2015-07-13
- Completion:
- 2016-07-02
Conditions
- Chronic Kidney Disease (CKD)
Interventions
- BIOLOGICAL
- OTHER
- DRUG